Occupational Therapists in New Haven, CT Accepting Medicare

26 Occupational Therapists found. Showing 21 - 26

Kelly Anne Quinn Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 118 Clinton Ave, New Haven, CT 06513 Phone: 203-562-7222

Ms. Jaclyn Bell Clifford-walter, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 543 Prospect St, New Haven, CT 06511 Phone: 617-365-7557

Keiona Bell, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 118 Clinton Ave, New Haven, CT 06513 Phone: 203-562-7222

Joon Hoon Lee, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17 Mourning Dove Cir, New Haven, CT 06513 Phone: 203-823-8305

Caitlin Condon, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Long Wharf Dr Ste 202, New Haven, CT 06511 Phone: 203-688-6561

Joon Lee, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 918 Quinnipiac Ave #2, New Haven, CT 06513 Phone: 203-823-6257

News Archive

WSJ examines project aimed at delivering drinking water to populations in India, China

The Wall Street Journal examines how a "rainwater harvesting project," called Aakash Ganga is delivering water to India's northern state of Rajasthan - one of the driest states in India - and expanding into China's Guiyang Municipality. The original project, supported by the World Bank, is set to expand from six villages in Rajasthan to "70 villages, to provide water security to 200,000 people," the newspaper writes.

Contrave, new weight loss pill gets FDA panel nod

A Food and Drug Administration (FDA) panel yesterday recommended the approval of Orexigen Therapeutics' weight loss drug Contrave. This is the first time a weight loss drug has received the nod. The vote went 13 to 7 for Contrave's approval and 11 to 8, with an abstention that additional studies be conducted on heart risks. Although experts agree to risks they believe the benefits outweigh the risks. Although the FDA is not compelled to go with the panel's recommendation, it more often than not does. The FDA will deliver its verdict by Jan. 31 2011.

Study shows ART has reduced immunosuppression and viremia among PHIV youth

The advent of antiretroviral therapy (ART) has transformed HIV from a death sentence into a chronic disease. In one of the largest studies of perinatally infected HIV (PHIV) patients to date, Agwu, et al, found that the proportion of patients on ART has increased and rates of viremia and advanced immunosuppression have decreased. But the rates of both markers in older patients are higher, according to an article in the Fall issue of The Journal of the Pediatric Infectious Diseases Society (JPIDS).

New report reveals steep rise in lung disease admissions to emergency departments during winter

An 80% rise in lung disease admissions to emergency departments in winter plays a major part in pushing our A&E services over the edge. Yet, only 10% of hospital trusts who responded to an FOI request had plans in place to make more beds available for respiratory patients warns a new report from the British Lung Foundation.

New kinds of optical sensors make MRI scans safer

Magnetic resonance scans will be safer for children and other patients needing anaesthesia, thanks to new kinds of optical sensors developed by a team of European researchers.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)